Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
11/05/2009 | WO2009133073A1 Propolis extract |
11/05/2009 | WO2009132463A1 New deodorization method and organoleptic improvement of marine oil extracts |
11/05/2009 | WO2009132457A1 Fgf-9 and its use relating to blood vessels |
11/05/2009 | WO2009112361A3 Synbiotic mixture |
11/05/2009 | WO2009101149A3 Anti-tumour effective paramyxovirus |
11/05/2009 | WO2009066283A3 Calcium-mediated effects of coral and methods of use thereof |
11/05/2009 | WO2007131218A8 Compositions and methods for modulating the immune system |
11/05/2009 | US20090274770 Cellular extracts |
11/05/2009 | US20090274769 Healing composition |
11/05/2009 | US20090274768 Fraktionen aus molkepermeat und deren verwendung zur pravention und therapie des typ-2 diabetes und des metabolischen syndroms |
11/05/2009 | US20090274728 Mutant Viruses |
11/05/2009 | US20090274715 Tick chitinase |
11/05/2009 | US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
11/05/2009 | US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof |
11/05/2009 | US20090274699 Ul16 binding protein 4 |
11/05/2009 | US20090274677 Antioxidant for use in cosmetic, medicated and pharmaceutical preparations |
11/05/2009 | US20090274673 Composition for topical treatment of acne |
11/05/2009 | US20090274672 Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same |
11/05/2009 | US20090274671 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
11/05/2009 | US20090274668 Combined Regulation of Neural Cell Production |
11/05/2009 | US20090274667 Retinal pigment epithelial stem cells |
11/05/2009 | US20090274666 B7-h1, a novel immunoregulatory molecule |
11/05/2009 | US20090274665 Stem Cells For Treating Lung Diseases |
11/05/2009 | US20090274664 Method of culturing vascular smooth muscle cells, culture device and medical material obtained by the culture |
11/05/2009 | US20090274663 Materials and Methods Relating to Cell Based Therapies |
11/05/2009 | US20090274661 Use of bifidobacterium longum for the prevention and treatment of inflammation |
11/05/2009 | US20090274660 Synthetic Stem Cell-like Tissue Healing and Regeneration Medication; nutraceuticals; glycosaminoglycan, polar surface active lipid such as lecithin, enantiomerically pure L-amino acids and glycine, vitamins, sorbitan fatty esters or grapeseed extract |
11/05/2009 | US20090274659 Compositions And Methods For Producing Fermentation Products And Residuals |
11/05/2009 | US20090274630 Red blood cell-derived vesicles as a nanoparticle drug delivery system |
11/05/2009 | US20090274627 Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same |
11/05/2009 | DE102008021756A1 Propolis-Extrakt Propolis Extract |
11/05/2009 | CA2726007A1 Vaccine compositions and methods |
11/05/2009 | CA2723276A1 Fgf-9 and its use relating to blood vessels |
11/05/2009 | CA2722909A1 Method for collecting functional cells in vivo with high efficiency |
11/05/2009 | CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
11/05/2009 | CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
11/05/2009 | CA2721981A1 Methods and kits for the treatment of inflammatory bowel disorder conditions |
11/04/2009 | EP2113569A1 Recombinant adenoviral vector and methods of use |
11/04/2009 | EP2113254A1 Compositions for treating an inflammatory auto-immune condition |
11/04/2009 | EP2113245A2 Substances capable of potentiating laminin 5 productivity in epidermal cells and their use |
11/04/2009 | EP1730264B1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
11/04/2009 | EP1650295B1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process |
11/04/2009 | EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders |
11/04/2009 | CN101569682A Medical composition for treating rheumatoid arthritis and preparation method and quality control method thereof |
11/03/2009 | US7612192 Neisseria genomic sequences and methods of their use |
11/03/2009 | US7612188 Modified vitamin K. dependent polypeptides |
11/03/2009 | US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
11/03/2009 | US7611895 Culturing eye tissues for treatment of vision defects; tissue engineering; grafting/surgery |
11/03/2009 | US7611833 Comprising an altered MAB1, MAB2, MAB3, or OLE1 gene; evaluating a substance as a positive strand RNA antiviral agent |
11/03/2009 | US7611831 Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix |
11/03/2009 | US7611723 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
11/03/2009 | CA2356896C Method for high yield extraction of paclitaxel from paclitaxel-containing material |
11/03/2009 | CA2187626C Aav-mediated delivery of dna to cells of the nervous system |
11/03/2009 | CA2181548C Zinc finger protein derivatives and methods therefor |
10/29/2009 | WO2009132186A1 Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use |
10/29/2009 | WO2009131712A2 Regulatory b cells and their uses |
10/29/2009 | WO2009131208A1 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
10/29/2009 | WO2009131200A1 Therapeutic agent for irritable bowel syndrome |
10/29/2009 | WO2009130600A2 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
10/29/2009 | WO2009130367A1 Method for maintaining intestial bacteria in balance |
10/29/2009 | WO2009130349A1 Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori |
10/29/2009 | WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
10/29/2009 | WO2009129561A1 Anti-viral nutraceutical |
10/29/2009 | WO2009108738A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
10/29/2009 | WO2009104911A3 Uses as agents for prophylaxis or treatment of cervical cancer |
10/29/2009 | WO2009102452A3 Compositions and methods for implantation of adipose tissue and adipose tissue products |
10/29/2009 | WO2009083643A3 Composition for treating sterile inflammation |
10/29/2009 | WO2009071920A3 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes |
10/29/2009 | US20090270514 Methods for Regulating Gelation of Polysaccharide Solutions and Uses Thereof |
10/29/2009 | US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
10/29/2009 | US20090270329 Methods of administering porcine b-domainless fviii |
10/29/2009 | US20090270310 Process for the preparation of a nutrient formulation |
10/29/2009 | US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids |
10/29/2009 | US20090269415 Novel therapeutic agent derived from marine organism |
10/29/2009 | US20090269407 Poly-alpha(1-4)glucopyranose-based matrices with hydrazide crosslinking |
10/29/2009 | US20090269406 Therapeutic uses of biocompatible biogel compositions |
10/29/2009 | US20090269388 Allograft bone composition having a gelatin binder |
10/29/2009 | US20090269387 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
10/29/2009 | US20090269385 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
10/29/2009 | US20090269361 Constructs for delivery of therapeutic agents to neuronal cells |
10/29/2009 | US20090269322 Compositions comprising selenium-rich yeast and yeast beta-glucan |
10/29/2009 | US20090269321 Immune Function Modulating Agents |
10/29/2009 | US20090269320 Variants of pigment epithelium derived factor and uses thereof |
10/29/2009 | US20090269318 Progenitor cells from wharton's jelly of human umbilical cord |
10/29/2009 | US20090269317 Irreversible electroporation to create tissue scaffolds |
10/29/2009 | US20090269316 Methods for Using a Three-Dimensional Stromal Tissue to Promote Angiogenesis |
10/29/2009 | US20090269315 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
10/29/2009 | US20090269314 Human cardiovascular progenitor cells |
10/29/2009 | US20090269313 Encapsulation system |
10/29/2009 | US20090269312 Methods, Systems, and Apparati for Cellular Therapeutic Agent Preparation and Delivery |
10/29/2009 | US20090269311 Method for treating multiple system atrophy |
10/29/2009 | US20090269310 Method for obtaining human smooth muscular cells and uses thereof |
10/29/2009 | US20090269309 Retinoic acid stimulates differentiation of pancreatic progenitor cells into insulin producing cells |
10/29/2009 | US20090269307 Edible Product Containing Ginseng Polysaccharides and Beneficial Bacteria |
10/29/2009 | DE102008020939A1 Preparing an extract e.g. for the regeneration of muscle tension, muscle-nerves and skin damage and scars and for the acceleration of wound healing, comprises extracting a body material of immunologically immature slaughtered animals |
10/29/2009 | CA2759833A1 Immunoisolation patch system for cellular transplantation |
10/29/2009 | CA2722475A1 Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use |
10/29/2009 | CA2722184A1 Regulatory b cells and their uses |
10/29/2009 | CA2721952A1 Retinal pigment epithelial stem cells |
10/29/2009 | CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |